Leukapheresis Market by top Key Players, Geographical Analysis & Future Forecast 2022
The Leukapheresis products market was valued at USD 18.5 million in 2017 and is expected to reach USD 27.7 million by 2023, at a CAGR of 7.4%.
(EMAILWIRE.COM, January 16, 2019 ) Factors contributing to the growth of these markets include the increasing incidence and prevalence of leukemia, growing demand for leukopaks for research applications, and increasing blood donations. The report analyzes the global leukapheresis market products market by type, application, end user, and region.
Speak To Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=20283148
Major players in the leukapheresis products market:
Asahi Kasei Medical (Japan), Fresenius (Germany), Haemonetics (US), Terumo BCT (US), STEMCELL Technologies (Canada), and Macopharma (France). Some prominent players in the leukopaks market are HemaCare (US), AllCells (US), StemExpress (US), PPA Research Group (US), Key Biologics (US), Caltag Medsystem (UK), ZenBio (US), Precision for Medicine (US), and BioIVT (US).
Leukapheresis Products Market, By Application
- Research Applications
- Therapeutic Applications
Geographically, the global leukapheresis products and leukopaks market is segmented into North America, Europe, Asia Pacific, and Rest of the World. In 2018, Asia Pacific is expected to account for the largest share of the leukapheresis products and leukopaks market, followed by North America and Europe. APAC’s prominence in this market is mainly due to the increase in regenerative medicine research in the region.
Download PDF: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=20283148
Media Contact
- Mr. Shelly Singh
- sales@marketsandmarkets.com